<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cyclosporine</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>A step forward in the treatment of chronic urticaria</title>
   	 <description>An international study involving dermatologists from the Hospital del Mar and Spanish subjects has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the symptoms of spontaneous chronic urticaria, a development that it is expected will significantly improve the quality of life of chronic urticaria sufferers.</description>
     <link>http://medicalxpress.com/news/2013-03-treatment-chronic-urticaria.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 20 Mar 2013 13:06:08 EST</pubDate>
	 <guid isPermaLink="false">news283003562</guid>
	 
</item>
<item>
     <title>Doctors' perceptions of psoriasis therapies vary</title>
   	 <description>(HealthDay)—Doctors who treat patients with psoriasis show wide variation in their beliefs about the safety and effectiveness of psoriasis treatments, according to a study published in the February issue of the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2013-02-doctors-perceptions-psoriasis-therapies-vary.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Feb 2013 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news279464855</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/doctorsperce.jpg" width="90" height="90" />
</item>
<item>
     <title>Belatacept after a kidney transplant: Minor added benefit for certain patients</title>
   	 <description>Belatacept (trade name Nulojix) has been approved since June 2011 to prevent a rejection reaction of the body to the donor organ (transplant) in adults who have received a kidney transplant. The Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the &quot;Act on the Reform of the Market for Medicinal Products&quot; (AMNOG).</description>
     <link>http://medicalxpress.com/news/2012-11-belatacept-kidney-transplant-minor-added.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 09 Nov 2012 13:17:20 EST</pubDate>
	 <guid isPermaLink="false">news271689428</guid>
	 
</item>
<item>
     <title>Circulating blood factor linked with a leading cause of kidney failure</title>
   	 <description>Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that the factor could be used to monitor the disease's progression as well as patients' response to different therapies. It might also be a therapeutic target of future treatments for this difficult-to-treat disease.</description>
     <link>http://medicalxpress.com/news/2012-11-circulating-blood-factor-linked-kidney.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 08 Nov 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news271613516</guid>
	 
</item>
<item>
     <title>Choice of psoriasis treatment affects CVD event rates</title>
   	 <description>(HealthDay)—Compared with other anti-psoriatic therapies, systemic anti-inflammatory treatment of patients with severe psoriasis with biologic agents or methotrexate is associated with a lower combined risk of death, myocardial infarction, and stroke, according to research published online Sept. 11 in the Journal of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-09-choice-psoriasis-treatment-affects-cvd.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 27 Sep 2012 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news267987071</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/choiceofpsor.jpg" width="90" height="90" />
</item>
<item>
     <title>Best post-transplant drug regimen identified for patients with new kidneys</title>
   	 <description>For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive drugs that protect transplanted organs can also cause serious side effects, including compromising patients' immunity to infection, cancer, and other threats. Finding the best combination and dosage of drugs has often proved difficult for physicians.</description>
     <link>http://medicalxpress.com/news/2011-07-post-transplant-drug-regimen-patients-kidneys.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 29 Jul 2011 03:17:05 EST</pubDate>
	 <guid isPermaLink="false">news231128211</guid>
	 
</item>


</channel>
</rss>
